*HER2
| 項目號 | 產品名稱 | 規格 | CAS | 包裝 | 細胞 | 靶點 | IC50 |
|---|---|---|---|---|---|---|---|
| L129338 | 二對甲苯磺酸拉帕替尼(GW-572016) | ≥98% | 388082-77-7 | 25mg,100mg,250mg,500mg,1g | 無細胞 | ErbB2 | 9.2 nM |
| EGFR | 10.8 nM | ||||||
| N126132 | Neratinib (HKI-272) | ≥99% | 698387-09-6 | 5mg,25mg,100mg | 無細胞 | HER2 | 59 nM |
| EGFR | 92 nM | ||||||
| C125447 | Canertinib (CI-1033) | ≥98% | 267243-28-7 | 10mg,50mg,250mg | EGFR | 1.5 nM | |
| ErbB2 | 9.0 nM | ||||||
| L126696 | Lapatinib | ≥99% | 231277-92-2 | 25mg,100mg,250mg,500mg,1g,5g | ErbB2 | 9.2 nM | |
| EGFR | 10.8 nM | ||||||
| C129397 | CP-724714 | ≥99% | 537705-08-1 | 5mg,10mg,25mg,50mg | HER2/ErbB2 | 10 nM | |
| D129347 | Dacomitinib (PF299804, PF299) | ≥99% | 1110813-31-4 | 5mg,10mg,50mg,250mg | EGFR | 6 nM | |
| A129380 | AZD8931 (Sapitinib) | ≥98% | 848942-61-0 | 5mg,10mg,50mg | 無細胞 | EGFR | 4 nM |
| ErbB2 | 3 nM | ||||||
| ErbB3 | 4 nM | ||||||
| C127191 | CUDC-101 | ≥98% | 1012054-59-9 | 10mg,25mg,50mg,10mmg,250mg | HDAC | 4.4 nM | |
| EGFR | 2.4 nM | ||||||
| HER2 | 15.7 nM | ||||||
| M129797 | Mubritinib (TAK 165) | ≥99% | 366017-09-6 | 10mg,50mg,250mg | T-474細胞 | HER2/ErbB2 | 6 nM |
| B126145 | AC480 (BMS-599626) | ≥98% | 714971-09-2 | 5mg,10mg,25mg,100mg | HER1 | 20 nM | |
| HER2 | 30 nM | ||||||
| A126830 | AEE788 (NVP-AEE788) | ≥97% | 497839-62-0 | 5mg,25mg,100mg | EGFR | 2 nM | |
| HER2/ErbB2 | 6 nM | ||||||
| T126234 | TAK-285 | ≥98% | 871026-44-7 | 1mg,5mg,10mg,50mg | HER2 | 17 nM | |
| EGFR(HER1) | 23 nM | ||||||
| T129799 | Tyrphostin AG 879 | ≥98% | 148741-30-4 | 5mg,25mg,100mg | HER2/ErbB2 | 1 μM | |
| N133726 | 去甲二氫愈創木酸 | ≥95% | 500-38-9 | 1g,5g | IGF-1R/HER2 | ||
| L193141 | 二甲苯磺酸拉帕替尼 一水合物 | 0.98 | 388082-78-8 | 1g,5g | EGFR | 10.8 nM | |
| ErbB2 | 9.2 nM | ||||||
| E107404 | (-)-表沒食子兒茶素沒食子酸 | 98% | 989-51-5 | 100mg,200mg,2.5g | EGF/HER-2 | ||
| E107403 | (-)-表沒食子兒茶素沒食子酸 | 分析標準品 | 989-51-5 | 20mg,100mg | EGF/HER-2 | ||
*HIF